Patent · US Active

Conjugates of synthetic TLR agonists and uses therefor

US9050376B2 · kind B2 · utility

24Cited by
54References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2014
Grant dateJun 9, 2015
Priority date
Expiry dateJun 19, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55555
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides TLR agonists and conjugates thereof useful in vaccines and to prevent, inhibit or treat a variety of disorders including pathogen infection and asthma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.